Effective implementation of quality improvement initiatives and team-based care is essential to overcoming treatment barriers, mitigating clinical inertia, and optimizing cardiovascular risk management. This episode highlights contemporary strategies to identify individuals at elevated risk for cardiovascular disease through the integration of novel biomarkers, including lipoprotein(a), and validated cardiovascular risk assessment tools such as the Pooled Cohort Equations, PREVENT, and coronary artery calcium scoring. Learn how these approaches provide a framework for tailoring preventive and therapeutic strategies, enabling timely treatment intensification, and ultimately improving clinical outcomes across diverse patient populations.

Cardiovascular Risk Beyond Traditional Predictors: The Independent Role of UACR and eGFR
245 views

Rural at Heart Community Connector in Pine Bluff, Arkansas
234 views

Building the Advanced Heart Failure Pipeline
122 views

Understanding Amyloidosis & Emerging Therapeutic Frontiers
35 views

Breakthroughs in ATTR-CM: CRISPR-Cas9 and the Evolving Trial Landscape
21 views

He learned CPR, then saved his friend's life: Wallis' Story
31 views